Grants-in-aid

We advertise for applications for grants-in-aid at the start of each year (for funding to start in January the following year).

Grants-in-aid support research for 1 to 3 years. They're awarded based on each project's:

• relevance to cancer,
• excellence,
• the value of the research, and
• the researcher's capacity to successfully complete the research described in the application.

While there are no specified priority areas for grants-in-aid research, currently most grants are for very high-quality basic research into the causes and prevention of cancer or clinical research that focuses on diagnosis and treatment.

All applications go through a rigorous peer-review process. The state Cancer Councils work in partnership with the National Health and Medical Research Council, which provides us with assessments and rankings.

In 2011 Cancer Council Victoria spent $3.2 million on grants-in-aid. Current recipients are below.

---

A/Prof Robin Anderson
Peter MacCallum Cancer Centre
Regulation of breast cancer metastasis by bone morphogenetic protein 4 (2011-2013)

Prof Leon Bach, Prof Greg Rice
Monash University
Insulin-like growth factor binding protein-6 and ovarian cancer (2011-13)

Prof David Bowtell, Dr Andreas Möller
Peter MacCallum Cancer Centre
Hypoxia signalling in the tumour microenvironment (2009-11)

Dr Michael Buchert, A/Prof Matthias Ernst
Ludwig Institute for Cancer Research
Molecular elucidation of PI-3K/mTor pathway as a therapeutic target in inflammation-associated (gastrointestinal) cancers (2012-14)

A/Prof Ian Campbell, A/Prof Kornelia Polyak
Peter MacCallum Cancer Centre
Identification of epigenetic and miRNA targets in primary ovarian cancer associated fibroblasts (2009-11)

A/Prof Ian Campbell, Dr Alison Trainer, A/Prof Lara Lipton, A/Prof Paul James, Dr Maria Doyle
Peter MacCallum Cancer Centre
Identification of novel genes predisposing to familial colorectal cancer by full exome sequencing (2012-14)

A/Prof Lynda Campbell, A/Prof Harshal Nandurkar, Dr Ruth MacKinnon
St Vincent's Health
A new leukaemia oncogene on chromosome 20 (2009-11)

Prof Jonathan Cebon (and Dr Lisa Ebert, 2010)
Ludwig Institute for Cancer Research
Regulatory T cells specific for human tumour antigens (2010-12)

Prof Christopher Christophi, Dr Eleanor Ager, Prof Peter Angus, Dr Vijayaragavan Muralidharan
Austin Health
Mechanisms of renin angiotensin system-regulated growth of colorectal liver metastases (2011-12)

Dr Colin Clyne
Prince Henry's Institute of Medical Research
Characterising the cancer-promoting role of LRH-1: Molecular mechanisms and animal model (2010-11)

A/Prof Alexander Dobrovic
Peter MacCallum Cancer Centre
Somatic DNA methylation and cancer predisposition: A new approach to identifying individuals at risk of cancer (2009-11)

A/Prof Alexander Dobrovic, Dr Thomas Mikeska
Peter MacCallum Cancer Centre
Constitutional DNA methylation: a new paradigm for predisposition to lung cancer (2012-13)

A/Prof Paul Ekert, Prof Angel Lopez
Murdoch Childrens Research Institute
Transcriptional and post-translational mechanisms regulating apoptosis in cytokine receptor signalling (2011-13)

Prof Peter Fuller, Dr Ann Drummond
Prince Henry's Institute of Medical Research
Molecular pathogenesis of granulosa cell tumours of the ovary (2010-12)

Dr Kieran Harvey
Peter MacCallum Cancer Centre
Phosphorylation-mediated regulation of the Hippo tumour suppressor pathway (2010-12)

A/Prof Ygal Haupt
Peter MacCallum Cancer Centre
A role for E6AP in the regulation of p53 in response to stress (2010-12)

Dr Christine Hawkins, A/Prof David Curtis, Dr Elizabeth Algar
La Trobe University
Are direct apoptosis inducers less mutagenic than chemotherapy drugs? (2012-14)

Prof Rodney Hicks, A/Prof Grant McArthur, Dr Jayesh Desai
Peter MacCallum Cancer Centre
The role of glucose metabolism in oncogene addiction (2010-12)

Dr Mark Hinds, Dr Catherine Day
Walter and Eliza Hall Institute of Medical Research
Structure and interactions of apoptosis regulators (2009-11)

Prof John Hopper, Dr Jennifer Stone, Dr Carmel Apicella, Dr Enes Makalic, Dr Daniel Schmidt, Dr Rob MacInnis
The University of Melbourne
Mammographic density of young women and their relatives (2012-14)

Dr Patrick Humbert
Peter MacCallum Cancer Centre
The role of cell polarity regulators in mammary gland development and breast cancer (2012-14)

Dr David Izon, Dr Andrew Wei
St Vincents Institute of Medical Research
Identification of leukaemia-initiating cells in mixed lineage leukaemia (2011-12)

A/Prof Brendan Jenkins
Monash Institute of Medical Research
Novel regulation of microRNAs by cytokine signalling pathways in gastric inflammation and cancer (2010-13)

A/Prof Ricky Johnstone
Peter MacCallum Cancer Centre
Epigenetic therapies for the treatment of acute myeloid leukemia (2012-14)

A/Prof Michael Kershaw, Dr Phillip Darcy
Peter MacCallum Cancer Centre
Investigations into differential responses to immunotherapy of orthotopic tumours compared to subcutaneous tumours (2011-13)

Dr Andrew Kneebone (NSW), Dr Scott Williams (VIC), Prof Gillian Duchesne (VIC), A/Prof Richard Fisher (VIC), A/Prof Mark Frydenberg (VIC)
Peter MacCallum Cancer Centre
A phase III trial comparing adjuvant versus salvage radiotherapy for high risk patients post radical prostatectomy (2008-11)

A/Prof Jun-Ping Liu
Dept of Immunology, Monash University (2009-10)
Murdoch Childrens Research Institute (2011)
Investigating the control mechanisms of telomere maintenance in cancer: a new interaction between telomerase and GAPDH (2009-11)

Dr Pavel Lobachevsky, Prof Roger Martin, Dr Olga Martin
Peter MacCallum Cancer Centre
Radioprotection by combination of DNA binding antioxidants and aminothiol radical scavengers (2012-14)

Prof Finlay Macrae (VIC), A/Prof Alex Boussioutas (VIC), Dr Julie Clarke (SA), Dr David Topping (SA), Dr Shusuki Toden (SA), Prof Patrick Lynch (USA), Prof Allan Spigelman (NSW), Dr Mark Appleyard (QLD), Dr Paul Hollington (SA), Dr Hooi Ee (WA), Prof Don Cameron (VIC)
Melbourne Health
The effects of butyrylated high amylose maize starch on polyposis in FAP volunteers (2011-13)

Prof Bruce Mann, Dr Anita Skandarajah, Dr Allison Rose, Dr Boon Chua, Prof John Forbes
Melbourne Health
PROSPECT - Post-operative Radiotherapy Omission in Selected Patients with Early breast Cancer Trial (2011-13)

Dr Matthew McCormack, Dr Wei Shi
Walter and Eliza Hall Institute of Medical Research
Identifying commonality amongst T cell oncogenes (2012-14)

Dr Belinda Parker, Prof Paul Hertzog
Peter MacCallum Cancer Centre
Silencing of Irf7 expression in breast cancer cells as a mechanism of immune escape during metastasis (2011-12)

A/Prof Wayne Phillips
Peter MacCallum Cancer Centre
Molecular mechanisms of action of PI3-kinase mutations: Studies in single cells using a novel microinjection approach (2009-11)

A/Prof Wayne Phillips
Peter MacCallum Cancer Centre
Identifying genetic changes that cooperate with PIK3CA mutation (2012)

Dr John Price, Dr Kent Hunter, Dr Jackie Wilce
Dept of Biochemistry and Molecular Biology, Monash University
Role of heat schock factor-1 in breast cancer metastasis (2009-11)

Dr Louise Purton, A/Prof Kong Wah Ng
St Vincent's Institute of Medical Research
Roles of retinoic acid receptors in bone and haemopoiesis (2010-12)

Prof Gail Risbridger
Monash Institute of Medical Research
Defining the relationships between estorgens, prostatitis and prostate cancer (2009-11)

Prof Julian Rood, Prof Martin Brown, Dr Glen Carter
Dept of Microbiology, Monash University
Clostridium-directed enzyme prodrug therapy (CDEPT): an innovative approach to treating cancer (2010-12)

Prof Jamie Rossjohn, Prof James McCluskey
Dept of Biochemistry and Molecular Biology, Monash University
A structural and functional investigation into tumour rejection by NKT cells (2010-12)

Prof Andrew Scott, Dr Vinochani Pillay, A/Prof John Mariadason, A/Prof Niall Tebbutt
Ludwig Institute for Cancer Research
siRNA therapies for colorectal cancer (2012-14)

Dr Stavros Selemidis, Dr Elizabeth Williams, Dr Grant Drummond
Dept of Pharmacology, Monash University
Novel pharmacological targets for suppression of tumour angiogenesis (2010-12)

Dr Christopher Slape, Dr David Curtis, Prof Stephen Jane
Bone Marrow Research Laboratories, Melbourne Health (2009-June 2011)
Alfred Hospital (June-December 2011)
Molecular analysis of myelodysplasia in the Nup98HoxD13 mouse model (2009-11)

Prof Mark Smyth, Dr Michelle Teng
Peter MacCallum Cancer Centre
Immunoregulation of the tumour microenvironment (2011-13)

A/Prof Melissa Southey, Prof David Goldgar
Pathology Department, University of Melbourne
Identification of the breast cancer susceptibility gene on chromosome 4 with next generation sequencing (2010-12)

Dr Trina Stewart
Peter MacCallum Cancer Centre
Use of anti-CCL2 mAb therapy as an adjuvant to reduce tumour growth and tumour-induced immunosuppression (2010-12)

A/Prof Mark Wright
Dept of Immunology, Monash University
The role of tetraspanins in adaptive cellular immunity (2009-11)

Email this page   Print friendly